Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

6 Nov 2014 07:00

RNS Number : 2805W
Wilmington Group Plc
06 November 2014
 



6 November 2014

 

Wilmington Group plc

 

Interim Management Statement

 

 

Wilmington Group plc ("Wilmington" or "the Group"), the provider of Information, Compliance and Education to professional markets, presents its Interim Management Statement for the period from 1 July 2014, based on the results for the three months ended 30 September 2014 with comments reflecting trading to date. This statement is also being made at the Group's Annual General Meeting being held today.

 

Trading Update

 

The Group has made a good start to the year with revenue up during the three months ended 30 September 2014 despite adverse currency effects. Our business is performing well against the comparative period in 2013 and in line with our expectations.

 

Banking & Compliance: ICT (compliance training) continues to secure major training programmes from international banks, and this has resulted in strong revenue growth during the three months ended 30 September 2014. As previously reported we have invested in additional resource to support the business' expansion, and despite this contribution to profits has grown strongly. AMT (banking training) which delivers most of its revenue and contribution during the summer months has again delivered revenue and contribution in line with our expectations, with a particularly strong performance from its graduate programmes in Hong Kong. This division does have significant international operations and has been adversely impacted by movements in exchange rates.

 

Pensions & Insurance: This division continues to deliver revenue and contribution growth and has maintained its high margins. ICP (company credit reporting), which had a record year last year, has seen a small fall in demand but has mitigated this to a large extent by good cost control. This division also has significant international operations and has therefore also been adversely impacted by movements in exchange rates year on year.

 

Healthcare: This division benefitted from a significant investment last year with five senior appointments which is reflected in a higher overhead base in the first quarter compared to the same period in 2013. We have seen positive overall revenue growth compared to the same period in the prior year despite the negative impact of the Euro on our French language medical news agency, Agence de Presse Médicale. It is too early to see if the challenging conditions have abated but we are encouraged by the good start to the year.

 

Legal: The Legal division has continued to experience challenging conditions although the rate of decline has moderated and some areas, particularly Bond Solon, continue to see growth. Our lower cost base has meant that the performance from the division has improved compared to the same period in 2013.

 

Business Intelligence: As anticipated, revenue is up slightly on the same period in 2013. This combined with a lower cost base resulted in contribution in line with our expectations and up on the same period in 2013.

 

Accountancy: The division has enjoyed a strong start to the year reflecting inter alia demand for face to face public course training. This additional revenue is reflected in the division's pleasing overall increase in contribution due to the operational gearing of the business.

 

Management

As previously announced, Pedro Ros assumed the role of Chief Executive on 1 October 2014 having joined the Board on 14 July 2014.

Net Debt

The Group's cash position remains robust benefitting from strong operational cashflows. Net debt as at 30 September 2014 was £32.6m (30 September 2013: £39.2m).

 

Outlook

The overall trading background has not changed significantly since the full year 2014 results announcement and the business is on track to meet our expectations for the full year.

We are progressing well on our review of the businesses and expect to provide an update during December 2014.

 

 

-End-

 

 

 

For further information, please contact:

Wilmington Group plc

020 7422 6800

Pedro Ros, Chief Executive

Tony Foye, Chief Finance Officer

FTI Consulting

020 3727 1000

Charles Palmer / Emma Appleton

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGGRCGUPCGMA
Date   Source Headline
17th Apr 202611:20 amRNSHolding(s) in Company
15th Apr 20263:56 pmRNSBoard changes
15th Apr 202611:21 amRNSSave As You Earn Options
11th Mar 202611:00 amRNSDirector Declaration
11th Mar 202611:00 amRNSDirector Declaration
26th Feb 20267:00 amRNSHalf-year Financial Report
11th Feb 20262:44 pmRNSNotice of half year-end results
21st Jan 202611:19 amRNSNotice of Half Year Results
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
5th Dec 20259:56 amRNSAcquisition of Conversia completed
28th Nov 20254:23 pmRNSDirector/PDMR Shareholding
28th Nov 202511:22 amRNSAcquisition of Conversia cleared to complete
25th Nov 20259:19 amRNSResult of AGM
10th Nov 20255:54 pmRNSDirectorate change
1st Oct 20252:51 pmRNSDirector/PDMR Shareholding
1st Oct 20252:49 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
22nd Sep 202512:48 pmRNSDirector/PDMR Shareholding- Replacement
22nd Sep 202511:52 amRNSDirector/PDMR Shareholding
22nd Sep 20257:00 amRNSFinancial results for the year ended 30 June 2025
5th Sep 202510:58 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSNotice of year-end results
29th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:03 amRNSProposed acquisition of Conversia
12th Aug 20257:00 amRNSDirector Declaration
1st Aug 20257:00 amRNSAppointment of Joint Corporate Broker
30th Jul 20257:00 amRNSStatement in relation to a potential acquisition
23rd Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20259:00 amRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:30 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.